About Us
Oncodrex’s discovery of unique molecular signatures of metastatic cancers allows the Company to develop targeted therapeutics for those cancers, as well as companion diagnostics to identify patients who will respond to the therapeutics. Combined, this provides a significant differentiator from the current standard of care.
The Team
Joe Brennan
Dr Shailly Varma Shrivastav
Dr Shailly Varma Shrivastav
Acting CEO
Over 25 years in healthcare company leadership including Genzyme, Acelity and as CEO of Innovative Trauma Care and neoSurgical.
Dr Shailly Varma Shrivastav
Dr Shailly Varma Shrivastav
Dr Shailly Varma Shrivastav
Chief Scientific Officer
A former Assistant Professor at the University of Winnipeg and an expert on cancer signaling and protein biomarkers.
Dr. Raminder Nirula
Dr Shailly Varma Shrivastav
Dr. Raminder Nirula
Chief Medical Officer
Chief, Division of Surgery, University of Utah.
Dr. Vijaykrishna Gadi
Dr Shailly Varma Shrivastav
Dr. Raminder Nirula
Scientific Advisor
Professor and Director of Medical Oncology & Associate Director, Translational Oncology, University of Illinois.